Tissue inhibitors of metalloproteinases: Evolution, structure and function

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1477, Issue 1-2, 2000, Pages 267-283

  Brew, Keith ^a   Dinakarpandian, Deendayal ^b   Nagase, Hideaki ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Matrix metalloproteinase; Tissue inhibitor

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ENZYME ACTIVE SITE; ENZYME STRUCTURE, FUNCTION AND VARIABILITY; ENZYME SUBSTRATE COMPLEX; EVOLUTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ENZYME PRECURSORS; EVOLUTION, MOLECULAR; GELATINASES; HUMANS; KINETICS; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034615550     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(99)00279-4     Document Type: Review

References (74)

1. Nagase H., Woessner J.F. Jr. Matrix metalloproteinases. J. Biol. Chem. 274:1999;21491-21494.
2. W.C. Parks, R.P. Mecham, Matrix Metalloproteinases, Academic Press, San Diego, 1998.
3. Williamson R.A., Marston F.A., Angal S., Koklitis P., Panico M., Morris H.R., Carne A.F., Smith B.J., Harris T.J., Freedman R.B. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem. J. 268:1990;267-274.
4. Murphy G., Houbrechts A., Cockett M.I., Williamson R.A., O'Shea M., Docherty A.J. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity [published erratum appears in Biochemistry 30 (1991) 10362]. Biochemistry. 30:1991;8097-8102.
5. Willenbrock F., Crabbe T., Slocombe P.M., Sutton C.W., Docherty A.J., Cockett M.I., O'Shea M., Brocklehurst K., Phillips I.R., Murphy G. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions a kinetic analysis of the inhibition of gelatinase A. Biochemistry. 32:1993;4330-4337.
6. Huang W., Suzuki K., Nagase H., Arumugam S., Van Doren S.R., Brew K. Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett. 384:1996;155-161.
7. Pohar N., Godenschwege T.A., Buchner E. Invertebrate tissue inhibitor of metalloproteinase structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. Genomics. 57:1999;293-296.
8. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74:1997;111-122.
9. Das S.K., Yano S., Wang J., Edwards D.R., Nagase H., Dey S.K. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev. Genet. 21:1997;44-54.
10. H. Nagase, in: N.M. Hooper (Ed.), Zinc Metalloproteases in Health and Disease, Taylor and Francis, London, 1996, pp. 153-204.
11. J.F. Woessner, Jr., in: W.C. Parks, R.P. Mecham (Eds.), Matrix Metalloproteinases, Academic Press, San Diego, 1998, pp. 1-14.
12. Blelloch R., Kimble J. Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegans. Nature. 399:1999;586-590.
13. Williamson R.A., Natalia D., Gee C.K., Murphy G., Carr M.D., Freedman R.B. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies. Eur. J. Biochem. 241:1996;476-483.
14. Williamson R.A., Martorell G., Carr M.D., Murphy G., Docherty A.J., Freedman R.B., Feeney J. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry. 33:1994;11745-11759.
15. Gomis-Rüth F.X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G.P., Bartunik H., Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 389:1997;77-81.
16. Williamson R.A., Carr M.D., Frenkiel T.A., Feeney J., Freedman R.B. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry. 36:1997;13882-13889.
17. Fernandez-Catalan C., Bode W., Huber R., Turk D., Calvete J.J., Lichte A., Tschesche H., Maskos K. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17:1998;5238-5248.
18. Tuuttila A., Morgunova E., Bergmann U., Lindqvist Y., Maskos K., Fernandez-Catalan C., Bode W., Tryggvason K., Schneider G. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution. J. Mol. Biol. 284:1998;1133-1140.
19. Murzin A.G. OB (oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J. 12:1993;861-867.
20. Murphy G., Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248:1995;496-510.
21. Liu Y.E., Wang M., Greene J., Su J., Ullrich S., Li H., Sheng S., Alexander P., Sang Q.A., Shi Y.E. Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J. Biol. Chem. 272:1997;20479-20483.
22. Amour A., Slocombe P.M., Webster A., Butler M., Knight C.G., Smith B.J., Stephens P.E., Shelley C., Hutton M., Knäuper V., Docherty A.J., Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435:1998;39-44.
23. Murphy G., Knäuper V. Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15:1997;511-518.
24. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell. Res. 8:1998;179-186.
25. Goldberg G.I., Strongin A., Collier I.E., Genrich L.T., Marmer B.L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:1992;4583-4591.
26. Bigg H.F., Shi Y.E., Liu Y.E., Steffensen B., Overall C.M. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J. Biol. Chem. 272:1997;15496-15500.
27. Pavloff N., Staskus P.W., Kishnani N.S., Hawkes S.P. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J. Biol. Chem. 267:1992;17321-17326.
28. Yang T.T., Hawkes S.P. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;10676-10680.
29. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:1997;151-160.
30. Overall C.M., Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J. Biol. Chem. 265:1990;21141-21151.
31. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature. 370:1994;61-65.
32. Butler G.S., Will H., Atkinson S.J., Murphy G. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur. J. Biochem. 244:1997;653-657.
33. Takino T., Sato H., Shinagawa A., Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270:1995;23013-23020.
34. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:1995;5331-5338.
35. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., van Westrum S.S., Crabbe T., Clements J., d'Ortho M.P., Murphy G. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273:1998;871-880.
36. Kinoshita T., Sato H., Okada A., Ohuchi E., Imai K., Okada Y., Seiki M. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem. 273:1998;16098-16103.
37. Itoh Y., Ito A., Iwata K., Tanzawa K., Mori Y., Nagase H. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J. Biol. Chem. 273:1998;24360-24367.
38. Muskett F.W., Frenkiel T.A., Feeney J., Freedman R.B., Carr M.D., Williamson R.A. High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J. Biol. Chem. 273:1998;21736-21743.
39. Nagase H., Suzuki K., Cawston T.E., Brew K. Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem. J. 325:1997;163-167.
40. Huang W., Meng Q., Suzuki K., Nagase H., Brew K. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases. J. Biol. Chem. 272:1997;22086-22091.
41. Meng Q., Malinovskii V., Huang W., Hu Y., Chung L., Nagase H., Bode W., Maskos K., Brew K. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1′ residue of substrate. J. Biol. Chem. 274:1999;10184-10189.
42. Butler G.S., Hutton M., Wattam B.A., Williamson R.A., Knäuper V., Willenbrock F., Murphy G. The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations. J. Biol. Chem. 274:1999;20391-20396.
43. Caterina N.C., Windsor L.J., Yermovsky A.E., Bodden M.K., Taylor K.B., Birkedal-Hansen H., Engler J.A. Replacement of conserved cysteines in human tissue inhibitor of metalloproteinases-1. J. Biol. Chem. 272:1997;32141-32149.
44. Will H., Atkinson S.J., Butler G.S., Smith B., Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271:1996;17119-17123.
45. Hutton M., Willenbrock F., Brocklehurst K., Murphy G. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A evidence for the existence of a low-affinity intermediate. Biochemistry. 37:1998;10094-10098.
46. Knäuper V., López-Otín C., Smith B., Knight G., Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271:1996;1544-1550.
47. Cawston T.E., Murphy G., Mercer E., Galloway W.A., Hazleman B.L., Reynolds J.J. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem. J. 211:1983;313-318.
48. Taylor K.B., Windsor L.J., Caterina N.C.M., Bodden M.K., Engler J.A. The mechanism of inhibition of collagenase by TIMP-1. J. Biol. Chem. 271:1996;23938-23945.
49. Olson M.W., Gervasi D.C., Mobashery S., Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272:1997;29975-29983.
50. Docherty A.J., Lyons A., Smith B.J., Wright E.M., Stephens P.E., Harris T.J., Murphy G., Reynolds J.J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 318:1985;66-69.
51. Gasson J.C., Golde D.W., Kaufman S.E., Westbrook C.A., Hewick R.M., Kaufman R.J., Wong G.G., Temple P.A., Leary A.C., Brown E.L., et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature. 315:1985;768-771.
52. Bertaux B., Hornebeck W., Eisen A.Z., Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol. 97:1991;679-685.
53. Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298:1992;29-32.
54. Stetler-Stevenson W.G., Bersch N., Golde D.W. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid- potentiating activity. FEBS Lett. 296:1992;231-234.
55. Hayakawa T., Yamashita K., Ohuchi E., Shinagawa A. J. Cell Sci. 107:1994;2373-2379.
56. Zhao W.Q., Li H., Yamashita K., Guo X.K., Hoshino T., Yoshida S., Shinya T., Hayakawa T. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J. Cell Sci. 111:1998;1147-1153.
57. Ritter L.M., Garfield S.H., Thorgeirsson U.P. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun. 257:1999;494-499.
58. Edwards D.R., Beaudry P.P., Laing T.D., Kowal V., Leco K.J., Leco P.A., Lim M.S. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int. J. Obes. Relat. Metab. Disord. 20:(Suppl. 3):1996;S9-S15.
59. Bian J., Wang Y., Smith M.R., Kim H., Jacobs C., Jackman J., Kung H.F., Colburn N.H., Sun Y. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis. 17:1996;1805-1811.
60. Ahonen M., Baker A.H., Kahari V.M. High level expression of tissue inhibitors of metalloproteinases-1, -2 and -3 in melanoma cells achieved by adenovirus mediated gene transfer. Adv. Exp. Med. Biol. 451:1998;69-72.
61. Baker A.H., George S.J., Zaltsman A.B., Murphy G., Newby A.C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer. 79:1999;1347-1355.
62. Valente P., Fassina G., Melchiori A., Masiello L., Cilli M., Vacca A., Onisto M., Santi L., Stetler-Stevenson W.G., Albini A. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int. J. Cancer 80 (1999) 485]. Int. J. Cancer. 75:1998;246-253.
63. Murphy A.N., Unsworth E.J., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell Physiol. 157:1993;351-358.
64. Chesler L., Golde D.W., Bersch N., Johnson M.D. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood. 86:1995;4506-4515.
65. Barasch J., Yang J., Qiao J., Tempst P., Erdjument-Bromage H., Leung W., Oliver J.A. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J. Clin. Invest. 103:1999;1299-1307.
66. Boujrad N., Ogwuegbu S.O., Garnier M., Lee C.H., Martin B.M., Papadopoulos V. Identification of a stimulator of steroid hormone synthesis isolated from testis [published erratum appears in Science (270) 1995 365]. Science. 268:1995;1609-1612.
67. Nothnick W.B., Soloway P., Curry T.E. Jr. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP- 1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. Biol. Reprod. 56:1997;1181-1188.
68. Smith M.R., Kung H., Durum S.K., Colburn N.H., Sun Y. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine. 9:1997;770-780.
69. Baker A.H., Zaltsman A.B., George S.J., Newby A.C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 101:1998;1478-1487.
70. Guedez L., Courtemanch L., Stetler-Stevenson M. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood. 92:1998;1342-1349.
71. Langton K.P., Barker M.D., McKie N. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J. Biol. Chem. 273:1998;16778-16781.
72. Felbor U., Weber B.H. Sorsby's fundus dystrophy. A genetically homogeneous disease. Ophthalmologe. 95:1998;287-290.
73. Tabata Y., Isashiki Y., Kamimura K., Nakao K., Ohba N. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features. Hum. Genet. 103:1998;179-182.
74. M. Carson, RIBBONS, in: R.M. Sweet, C.W. Carter (Eds.), Methods Enzymol. 277 (1997) 493-505.